Decline of erythromycin resistance of group A streptococci in Japan

K Fujita1, K Murono, M Yoshikawa

  • 1Department of Pediatrics, Asahikawa Medical College, Japan.

Insights

Group A Streptococcus (GAS) infections in children showed prevalent M serotypes 12, 4, 1, 3, and 28. Antibiotic resistance to erythromycin and tetracycline decreased over time, with no resistance to penicillin G.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pediatrics

Background:

  • Group A Streptococcus (GAS) is a significant bacterial pathogen causing various infections in children.
  • Understanding the serotypes and antibiotic resistance patterns of GAS is crucial for effective treatment and public health surveillance.
  • This study examines GAS isolates from children over a decade to assess epidemiological trends.

Purpose of the Study:

  • To serologically type Group A Streptococcus isolates from children with various infections.
  • To determine the antibiotic susceptibility patterns of these GAS isolates over a 10-year period.
  • To identify trends in antibiotic resistance, particularly for commonly used antimicrobials.

Main Methods:

  • Serological typing was performed on 670 Group A Streptococcus isolates collected from children between 1981 and 1990.
  • Antibiotic susceptibility testing was conducted for penicillin G, cephalexin, erythromycin, lincomycin, chloramphenicol, and tetracycline.
  • Isolates were categorized based on clinical presentation: pharyngitis, scarlet fever, suppurative, and nonsuppurative infections.

Main Results:

  • The most prevalent M serotypes identified were 12, 4, 1, 3, and 28.
  • No resistance was observed to penicillin G and cephalexin among all 670 isolates.
  • Resistance to erythromycin and lincomycin decreased significantly after 1983, with most resistant strains being M type 12.
  • Chloramphenicol resistance mirrored erythromycin resistance trends, while tetracycline resistance declined from 60% to under 20%.

Conclusions:

  • Penicillin G and cephalexin remain highly effective against Group A Streptococcus in this pediatric cohort.
  • A notable decrease in erythromycin, lincomycin, and tetracycline resistance was observed over the study period.
  • M serotype 12 was disproportionately associated with erythromycin resistance, highlighting the importance of serotype-specific resistance monitoring.

Related Concept Videos

Antibiotic Selection01:45

Antibiotic Selection

Researchers use antibiotic resistance genes to identify bacteria that possess a plasmid containing their gene of interest. Antibiotic resistance naturally occurs when a spontaneous DNA mutation creates changes in bacterial genes that eliminate antibiotic activity. Bacteria can share these new resistance genes with their offspring and other bacteria. The overuse and misuse of antibiotics have created a public health crisis, as resistant and multi-resistant bacteria continue to develop.Antibiotic...
Stringent Response in E. coli01:23

Stringent Response in E. coli

Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...